1-(3-tert-butyl-4-piperidin-1-ylphenyl)prop-2-yn-1-ol 、 4-碘苯甲酸 在
cupric iodide 、 双三苯基磷二氯化钯 作用下,
以650 mg of 4-[3-(3-tert-butyl-4-piperidin-1-ylphenyl)-3-hydroxyprop-1-ynyl]benzoic acid are obtained in the form of a beige solid (Mp=112° C., yield=46%)的产率得到4-[3-(3-tert-butyl-4-piperidin-1-ylphenyl)-3-hydroxyprop-1-ynyl]benzoic acid
参考文献:
名称:
NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS
3-tert-butyl-4-piperidin-1-ylbenzaldehyde 、 、 乙炔基溴化镁 以890 mg of 1-(3-tert-Butyl-4-piperidin-1-ylphenyl)prop-2-yn-1-ol are obtained in the form of a colourless oil (yield=82%)的产率得到1-(3-tert-butyl-4-piperidin-1-ylphenyl)prop-2-yn-1-ol
参考文献:
名称:
NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS
RAR receptor agonist ligands and use thereof in human medicine and cosmetics
申请人:Galderma Research & Development
公开号:US08163952B2
公开(公告)日:2012-04-24
The invention relates to compounds corresponding to general formula (I) below:
to the compositions containing same, to methods for the preparation thereof and to the use thereof in pharmaceutical compositions for use in human or veterinary medicine, or else in cosmetic compositions.